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Abstract
Epigenetic mechanisms are gatekeepers for the gene expression patterns that establish
and maintain cellular identity in mammalian development, stem cells and adult homeostasis.
Amongst many epigenetic marks, methylation of histone 3 lysine 4 (H3K4) is one of the
most widely conserved and occupies a central position in gene expression. Mixed lineage
leukemia 1 (MLL1/KMT2A) is the founding mammalian H3K4 methyltransferase. It was dis-
covered as the causative mutation in early onset leukemia and subsequently found to be
required for the establishment of definitive hematopoiesis and the maintenance of adult
hematopoietic stem cells. Despite wide expression, the roles of MLL1 in non-hematopoietic
tissues remain largely unexplored. To bypass hematopoietic lethality, we used bone marrow
transplantation and conditional mutagenesis to discover that the most overt phenotype in
adult Mll1-mutant mice is intestinal failure. MLL1 is expressed in intestinal stem cells (ISCs)
and transit amplifying (TA) cells but not in the villus. Loss of MLL1 is accompanied by loss of
ISCs and a differentiation bias towards the secretory lineage with increased numbers and
enlargement of goblet cells. Expression profiling of sorted ISCs revealed that MLL1 is
required to promote expression of several definitive intestinal transcription factors including
Pitx1, Pitx2, Foxa1, Gata4, Zfp503 and Onecut2, as well as the H3K27me3 binder, Bahcc1.
These results were recapitulated using conditional mutagenesis in intestinal organoids. The
stem cell niche in the crypt includes ISCs in close association with Paneth cells. Loss of
MLL1 from ISCs promoted transcriptional changes in Paneth cells involving metabolic and
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stress responses. Here we add ISCs to the MLL1 repertoire and observe that all known
functions of MLL1 relate to the properties of somatic stem cells, thereby highlighting the sug-
gestion that MLL1 is a master somatic stem cell regulator.
Author summary
The ability of stem cells to replenish cellular lineages is critical for the maintenance and
integrity of postnatal life. In mammals, the blood and the intestinal lining are two of the
highest turnover tissues and both are anchored by stem cells. For blood, hematopoeitic
stem cells require MLL1 (mixed lineage leukemia), which is an epigenetic regulator that
methylates histone 3 on lysine 4 (H3K4). MLL1 was discovered because it is mutated in
about 10% of all human leukemias prominently including early onset childhood leuke-
mias. In this study we show that MLL1 is also required for maintenance of intestinal stem
cells (ISCs). MLL1 is expressed in the intestinal crypt, which harbors the ISC niche and
transit amplifying cells but is not expressed in the intestinal villi that line the gut. Condi-
tional mutagenesis of Mll1 in adult mice rapidly leads to intestinal failure, wasting and
death. ISCs are lost and the niche is perturbed. Loss of ISC identity can be recapitulated
by conditional mutagenesis of Mll1 in intestinal organoids. In ISCs, MLL1 is required to
maintain the expression of several DNA binding transcription factors that are implicated
in regulating ISC cellular identity. Hence we report that two mammalian tissues with very
high turnover depend upon MLL1 to maintain their respective stem cells. Together with
other indications, MLL1 appears to be specifically related to adult stem cell properties.
Introduction
Stem cells are cornerstones of tissue biology, ensuring homeostasis and regeneration in many
organs, including epithelial tissues such as skin, intestine and mammary gland [1]. Stem cells
are characterized by multipotency, which is the ability to differentiate into a restricted number
of defined cell types, and self-renewal, which is the capacity to undergo infinite replicative
cycles without losing stem cell identity [2]. The remarkable capacities of stem cells, particularly
the restricted specificities of multipotency, rely on interplays between specific transcription
factors and distinct epigenetic landscapes. Whereas many transcription factors involved in
stem cell maintenance and differentiation have been defined, epigenetic contributions are
proving more elusive. For example, the transcription factor hierarchies in the stem cell para-
digm, hematopoiesis, have been elegantly dissected [3]. However the contributions of DNA
and histone methyltransferases to hematopoiesis are still emerging and indicate both specifici-
ties and the deeper complexities of epigenetic regulation [4–8].
Methylation of histone 3 on lysine 4 (H3K4) is one of the most conserved and widespread
epigenetic systems [9]. H3K4 is methylated in euchromatic regions, with trimethylated H3K4
(H3K4me3) on nucleosomes surrounding active promoters, H3K4me2 marking transcribed
regions and H3K4me1 relating to enhancers and active chromatin in general [10–14]. Mam-
mals have six Set1/Trithorax-related H3K4 methyltransferases (H3K4MTs) that are encoded
by three pairs of paralogous sister genes namely, Mll1 (Kmt2a) and Mll2 (Kmt2b), Mll3
(Kmt2c) and Mll4 (Kmt2d), Setd1a (Kmt2f) and Setd1b (Kmt2g). Each of the six H3K4MTs
resides in their own, large, protein complex. However all six complexes are based on a four
membered scaffold termed WRAD for the subunits WDR5, RBBP5, ASH2L and DPY30 [15]
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or sometimes called COMPASS [9]. Functional differences between the six complexes poten-
tially arise from the presence of additional subunits, which are usually shared by paralogous
pairs or sometimes uniquely found in one of the six complexes. For example, MENIN is a sub-
unit of both MLL1 and 2 complexes [16] but so far, no subunit unique to either paralogous
complex has been described.
Mixed lineage leukemia (MLL1) was the first mammalian gene identified as a Trithorax
homologue and subsequently found to encode a mammalian Set1/Trithorax-type H3K4MT
[17,18]. In mice, MLL1 is first required at embryonic day 12.5 (E12.5) for definitive hemato-
poiesis [19,20] and also for the maintenance of adult hematopoietic stem cells (HSCs) [21,22].
MLL1, but not its paralogue, MLL2, is a proto-oncogene because it is activated by chromo-
somal translocations to promote leukemias, notably without additional mutagenesis [23,24].
Over 80 translocation partners have been identified including AF6 and AF9 [25]. Mouse stud-
ies indicated that MLL1-AF6 and -AF9 leukemias rely on MLL2 expression [6] and MLL1-AF9
leukemiogenesis is entirely conveyed by overexpression of HOXA9 [26]. Conditional muta-
genesis has also revealed MLL1 functions in satellite cells [27] and postnatal neural stem cells
(NSCs) [28]. These observations raise the possibility that MLL1 regulates specific functions in
stem cell compartments.
Due to the high turnover and hierarchical architecture of the intestinal epithelium, intesti-
nal stem cells (ISCs) have become an adult stem cell paradigm. ISCs have been identified as
either actively cycling crypt base columnar cells (CBCs) or quiescent label-retaining cells
(LRCs) located at the +4 position from the crypt base [29]. LGR5 (Leucine-rich repeat-con-
taining G protein-coupled receptor 5) is the characteristic marker for the CBC class of ISCs
[30], which generates the transit amplifying (TA) daughter cells. Proliferation of the TA cells
generates the cells that line the villi: absorptive enterocytes, secretory goblet, enteroendocrine;
as well as Paneth cells [31]. Except for Paneth cells, these cell types take 3 to 5 days to migrate
out of the crypt up the villi, where they are shed into the intestinal lumen. Paneth cells stay in
the crypt and interweave with ISCs to form the intestinal stem cell niche that is sustained by
Wnt signaling [31,32]. Quiescent LRCs serve as a stem cell reserve to replace damaged ISCs
and are active only during stress or injury [33]. Enterocytes, preterminal enteroendocrine
cells, goblet cell precursors and Dll1+ secretory progenitors are also notable for their plasticity
and can serve as a reservoir for lost stem cells [34–36]. Mature Paneth cells also show an
injury-activated conversion to a stem cell like state [37]. Together with new perceptions in
hematopoiesis [4,6,38], the dynamic plasticity of the intestinal crypt has expanded the stem
cell paradigm [39], especially during replenishment after damage or inflammation.
To examine whether MLL1 plays non-hematopoietic roles in the adult, we employed
ligand-induced conditional mutagenesis [40,41] using a tamoxifen-inducible Rosa26-CreERT2
line (RC) [42] for near-ubiquitous Cre recombination to discover that MLL1 is required for
the maintenance of the ISC compartment and the balance between secretory and absorptive
cell lineages in the adult intestine.
Results
Intestinal functions collapse after loss of MLL1 in adult mice
To explore MLL1 functions, we utilized a multipurpose allele that can be converted from one
state to another using FLP and Cre recombination (S1A–S1C Fig) [43,44]. Homozygous
embryos carrying the targeted gene trap allele, Mll1A/A, developed normally until E12.5 when
they displayed pallor of the liver and were smaller (S1D Fig). After E13 no live Mll1A/A
embryos were found (S1 Table). After FLP and Cre recombination, Mll1FC/FC embryos carry-
ing the frame-shifted allele displayed the same phenotype indicating that both A and FC are
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true null alleles as expected from the loss of MLL1 protein [45]. Furthermore the Mll1A/A and
Mll1FC/FC phenotype recapitulated another likely null allele [6]. Homozygous mice from these
three mutant alleles present the same embryonic lethality due to the failure to engage definitive
hematopoiesis [21]. Consequently we suggest that the diverse early developmental phenotypes
reported previously for mutations in Mll1 [46,47] were likely due to dominant negative Mll1 alleles.
To identify postnatal roles of MLL1, ligand-induced conditional mutagenesis using
Rosa26-CreERT2 (RC) was applied to two month old adults. Mice lacking MLL1 developed
severe bone marrow cytopenia and died or had to be sacrificed on average within two weeks
(Fig 1A and 1B). As previously reported using the same conditional allele, in vitro deletion of
Mll1 in KSL-enriched HSCs from Mll1F/F; RC/+ mice resulted in significant downregulation of
Hoxa9, Meis1, Mecom/Evi1 and Prdm16 [6].
To bypass the bone marrow related lethality and thereby uncover non-hematopoietic phe-
notypes, bone marrow from wild type (wt) B6.SJL mice was transplanted into lethally irradi-
ated Mll1F/+; RC/+ or Mll1F/F; RC/+ mice. After stable engraftment tamoxifen gavage induced
widespread Cre-mediated excision of Mll1 (Fig 1C). Examination of the bone marrow con-
firmed the successful and near-complete reconstitution of the hematopoietic stem cell com-
partment by wt donor cells. FACS analysis for KSL-Slam enriched HSCs showed comparable
frequencies in bone marrow transplanted (BMTx) Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ mice with
the hematopoietic compartment comprised only of wt cells of CD45.1 origin (Fig 1C). Notably,
the BMTx Mll1FC/FC; RC/+ mice suffered from diarrhea and wasting but heterozygous BMTx
Mll1FC/+; RC/+ did not (Fig 1D). These data indicate that MLL1 is not only required in the
hematopoietic compartment but is similarly critical elsewhere.
The small and large intestine harbor stem cell compartments at the base of the intestinal
crypts. In the crypt, MLL1 is expressed in ISCs and the TA compartment, whereas it is absent
in differentiated cells above the TA compartment (Figs 1E and S1E) [48]. RNA profiling of
sorted ISCs and Paneth cells confirmed expression of Mll1 and the other five H3K4MTs in
both cell types however all are more strongly expressed in ISCs (S1F Fig). In the mutant small
intestine of BMTx Mll1FC/FC; RC/+ mice, expression of MLL1 was efficiently ablated and ISC
markers OLFM4 (olfactomedin 4) and SOX9 were lost (Fig 2A). Concordantly, proliferation
in the crypt was reduced as revealed by strongly reduced expression of the mitotic marker
Ki67 (Fig 2A). However, no apparent changes in global H3K4 mono-, di- and trimethylation
in the intestinal epithelium of Mll1FC/FC; RC/+ mice were observed (S1G Fig).
Shortened villi with distorted morphology including vacuolar structures at the tip indicated
diminished replenishment of cells into the villus (Fig 2B). Furthermore we observed increased
numbers of enlarged goblet cells distributed irregularly along the villus and also ectopically in
the crypt (Fig 2B). However, Paneth cells appeared unchanged possibly due to their longer
life span (Fig 2C). Similarly, as evaluated by chromogranin A and alkaline phosphatase, the
enteroendocrine and absorptive lineages appeared to be unaffected (Fig 2C).
Without bone marrow rescue, tamoxifen-induced conditional mutagenesis of Mll1
(Mll1FC/FC; RC/+ mice) showed the same defects with depletion of ISCs, decreased proliferation
and a distortion of the secretory lineage (S2A–S2D Fig). Differentiation into the enteroendo-
crine and absorptive lineage was also apparently unaffected (S2E Fig). Notably the hallmark of
Wnt signaling, nuclear β-catenin, was also unaffected (S2F Fig).
Intestinal epithelium-specific Mll1 conditional mutagenesis recapitulates
ubiquitous deletion
To delete Mll1 exclusively in the adult intestine we employed the tamoxifen-inducible gut epi-
thelium-specific Villin-CreERT2 line (Vil-Cre-ERT2) [49]. After tamoxifen administration
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about half (10/18) of the Mll1FC/FC; Vil-Cre-ERT2/+ mice lost weight compared to control mice.
These mice displayed wasting and were mostly analyzed three to four weeks after tamoxifen
induction (Fig 3A and 3B). Compared to Mll1FC/+; Vil-Cre-ERT2/+ littermates, OLFM4 and SOX9
expression, and proliferation were markedly decreased, goblet cells were enlarged and
increased in number whereas Paneth and enteroendocrine cell numbers were unchanged (Fig
3C and 3D). However the rest (8/18) of the Mll1FC/FC; Vil-Cre-ERT2/+ mice did not display wast-
ing and survived (Fig 3A), which is a result we attribute to insufficient Cre recombination by
Vil-Cre-ERT2 as noted before [49,50], and the regenerative capacities of the intestinal crypt
Fig 1. Loss of MLL1 in adult mice. (A) Giemsa-stained sections from the femur of Mll1FC/+; RC/+ and Mll1FC/FC; RC/+
mice. Two weeks after the last tamoxifen gavage mice were sacrificed and the femurs were dissected, decalcified,
sectioned and stained. Bone marrow cellularity was severely decreased in Mll1FC/FC; RC/+ mice. Scale bar 100 μm. (B)
Kaplan-Meier survival curve. The first day of tamoxifen gavage was day zero. All Mll1FC/+; RC/+ mice (n = 25) survived
whereas all Mll1FC/FC; RC/+ mice (n = 33) died within 33 days after tamoxifen induction with a median survival of 11
days. (C) Scheme of the experimental setup for bone marrow transplantation. Donor bone marrow from B6.SJL
(CD45.1+) mice was transplanted into lethally irradiated Mll1F/+; RC/+ and Mll1F/F; RC/+ recipients (CD45.2+). Blood
chimerism (BC) was measured three times. After 30 weeks Mll1 deletion was achieved by administrating tamoxifen
(TAM). FACS analysis for KSL-Slam enriched HSCs (Kit+ Sca1+ Lin- CD48- CD150+ CD34- CD135-) showed
comparable numbers in BMTx Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ mice. Dot plots show Lin- CD48- CD150+ CD34-
CD135- gated bone marrow (BM) cells of indicated genotypes resolved for the expression of c-Kit and Sca-1. Donor
and host cells are distinguished by surface markers CD45.1 and CD45.2. (D) Kaplan-Meier analysis for the onset of
diarrhea. Tamoxifen was given by gavage for 6 days to Mll1F/+; RC/+ (n = 6) and Mll1F/F; RC/+ (n = 8). The first day of
tamoxifen gavage was day zero. While all BMTx mice with the genotype Mll1FC/+; RC/+ remained healthy, all BMTx
Mll1FC/FC; RC/+ mice developed diarrhea with a median of 16.5 days. (E) Antibody staining (brown) showed that MLL1
is expressed in crypts of the small and large intestine but absent in the villus (hematoxylin, purple). Scale bars are
50 μm.
https://doi.org/10.1371/journal.pgen.1009250.g001
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Fig 2. Mll1 deletion in BMTx mice leads to loss of stem and proliferating cells and increased goblet cells. (A)
Antibody stainings showed reduced MLL1, OLFM4 and SOX9 expression in BMTx Mll1FC/FC; RC/+ intestine compared
to controls. Hematoxylin was used as a counterstain for MLL1 and OLFM4 immunohistochemistry (IHC). Expression
of Ki67, a marker for proliferating cells was reduced in BMTx Mll1FC/FC; RC/+ mutant intestinal sections. Arrowheads
point toward proliferating ISCs. Alcian blue was used as a counterstain for SOX9 and Ki67 IHC, which also revealed
enlarged goblet cells (turquoise) in the crypts of BMTx Mll1FC/FC; RC/+ sections. Scale bars are 50 μm. (B) PAS stain to
examine goblet cells in villi and crypts of BMTx intestine. Black arrowheads point towards vacuolar structures. Yellow
arrowhead points to a mislocalized goblet cell in BMTx Mll1FC/FC; RC/+ crypt. Left panels scale bar 100 μm; middle
panels scale bar 50 μm. GOB5 antibody staining of BMTx Mll1FC/FC; RC/+ intestinal sections. Right panels scale bar
100 μm. (C) Left panels; lysozyme antibody staining reveals that Paneth cell numbers remain unchanged. Arrowheads
point at Paneth cells. Alcian blue was used as a counterstain and marks goblet cells (turquoise). Middle panels;
chromogranin A antibody stain, arrowheads point to the sparse enteroendocrine cells (dark brown) in the villi. Right
panels; red enterocytes (arrowheads) covering the villi were visualized by alkaline phosphatase staining. Hematoxylin
was used as a counterstain for chromogranin A IHC and alkaline phosphatase histochemical staining. Scale bars are
50 μm.
https://doi.org/10.1371/journal.pgen.1009250.g002
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[31]. Concordant with this explanation, some of the surviving Mll1FC/FC; Vil-Cre-ERT2/+ mice sec-
tioned at 4 weeks stained strongly for OLFM4 and Ki67, but also had elevated and enlarged
goblet cells (S2G Fig), indicating that Cre deletion had provoked alterations in the crypt during
regenerative recovery.
To gather more evidence regarding mechanism and the temporal order of events after loss
of MLL1, we analyzed intestinal sections shortly after tamoxifen induction. One to two weeks
after the first tamoxifen gavage, the stem cell marker, OLFM4 and the proliferation indicator,
Ki67, were markedly decreased. However only a slight increase in the goblet cell population in
Mll1FC/FC; Vil-Cre-ERT2/+ intestinal sections was observed (Fig 3E) indicating that changes in
ISCs preceded other alterations.
Transcriptome analysis identifies key intestinal transcription factors as
central to the crypt stem cell niche
For transcriptome analysis, ISCs and Paneth cells were sorted using a FACS strategy 4 and 10
days after the final tamoxifen administration from Mll1FC/+; Lgr5-eGFP-CreERT2/+ and Mll1FC/FC;
Lgr5-eGFP-CreERT2/+ littermates (S3 Fig). Using 75 base-pair reads, 20–37 million reads per sample
with high levels of uniqueness (70–77% in Lgr5+ ISCs and 60–76% in Paneth cells; S4A–S4C
Fig) and comparable mapability (99%) were obtained. Principal component analysis (PCA)
revealed that our datasets are in good agreement with published datasets obtained from sorted
ISCs and Paneth cells [37,51] (S4D Fig).
We applied DESeq2 to analyze differentially expressed genes (DEGs). In the 4 day Lgr5+
stem cell profile, only 87 and 49 genes were up- or downregulated after removal of MLL1 at
5% FDR (false discovery rate) (Fig 4A and S1 Data). However, none of the upregulated tran-
scripts were increased by more than 2-fold and by DAVID analysis were mainly related to
diverse terms such as ’response to metal ion’, ’organic acid metabolic process’ and ’regulation
of lipid metabolic process’ (Fig 4B). In contrast the most significant terms associated with the
downregulated mRNAs were ’regulation of gene expression’, ’epithelial cell differentiation’
and ’cell proliferation’ (Fig 4B). The 10 day profile revealed 179 DEGs, of which 105 were upre-
gulated, 74 were downregulated with significant overlaps to the 4 day profile (S1 Data).
Gene set enrichment analysis (GSEA) of both 4 and 10 day ISC profiles revealed that overall
ISC signature genes were downregulated whereas goblet cell signature genes were upregulated
(Figs 4C, 4D, 4F and S5A and S5B), which concords with our immunohistochemical analyses.
We focused on the overlap between the 4 and 10 day downregulated mRNAs. The transcrip-
tion factors Pitx2, Foxa1, Zfp503/Nolz1, Pitx1, Onecut2 and Gata4 are prominent (Table 1 and
Fig 4E). The expression of Foxa1 and Pitx2 was evaluated by qRT-PCR with good agreement
Fig 3. Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. (A) Kaplan-Meier survival
curve. Tamoxifen was given by gavage for 6 days to mice with the genotype Mll1FC/+; Vil-Cre-ERT2/+ (n = 12) and Mll1FC/
FC; RC/+ (n = 18). The first day of tamoxifen gavage was day zero. The median survival of mutants is 24 days after
tamoxifen. (B) Percent of weight loss of Mll1FC/+; Vil-Cre-ERT2/+ (n = 6) and of Mll1FC/FC; Vil-Cre-ERT2/+ (n = 10) mice.
Mean ± s.d. is shown (p = 0.007, Student’s t-test). (C) Decrease in ISC markers, OLFM4 and SOX9 in Mll1FC/FC; Vil-Cre-
ERT2/+ intestinal sections. SOX9+ ISCs in Mll1FC/+; Vil-Cre-ERT2/+ intestinal sections are marked with red arrowheads.
Proliferating cells in the TA compartment as well as proliferative ISCs (arrowhead) are reduced in Mll1FC/FC; Vil-Cre-
ERT2/+ sections. Alcian blue was used as a counterstain after staining for SOX9 and Ki67 and marks goblet cells
(turquoise). Scale bars are 100 μm for OLFM4 and 50 μm for SOX9 and Ki67. (D) Left panels; alcian blue staining of
goblet cells with nuclear fast red (NFR) to stain nuclei. Middle panels; Paneth cells visualized by staining of granules
containing lysozyme (arrowheads). Right panels; enteroendocrine cells stained with chromogranin A antibody (brown;
arrowheads) in the villi. Scale bars are 100 μm. (E) Left and middle panels; antibody stainings showed reduced OLFM4
and Ki67 expression in Mll1FC/FC; Vil-Cre-ERT2/+ intestine compared to controls, one week after the first gavage.
Hematoxylin was used as a counterstain for OLFM4 and alcian blue was used for Ki67 IHC. Right panel; alcian blue
staining of goblet cells with NFR to stain nuclei, one week after the first gavage. Scale bars are 100 μm.
https://doi.org/10.1371/journal.pgen.1009250.g003
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Fig 4. RNA profiling of Mll1FC/FC; Lgr5-eGFP-CreERT2/+ and control ISCs. (A) ISCs were sorted from control (Mll1FC/+;
Lgr5-eGFP-CreERT2/+) (n = 4) and Mll1FC/FC; Lgr5-eGFP-CreERT2/+ (n = 4) mice 4 days after tamoxifen induction was
completed and subjected to RNA profiling. MA plot visualizing the log2-fold change differences according to
expression levels. Red dots represent significant DEGs at a 5% FDR. (B) Plots show biological processes (BP) that are
enriched in genes up- or downregulated in Mll1FC/FC; Lgr5-eGFP-CreERT2/+ compared to control ISCs. Analysis was
PLOS GENETICS MLL1 is required for maintenance of intestinal stem cells
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performed using the gene ontology (GO)/BP/FAT database of DAVID 6.8. (C) (D) GSEA shows significant negative or
positive correlation of genes from the stem (C) and goblet cell (D) signature gene set in Mll1FC/FC; Lgr5-eGFP-CreERT2/+
compared to control ISCs (4 days after tamoxifen). The signature gene sets originate from [87]. NES: normalized
enrichment score. (E) DESeq normalized counts for genes coding for transcription factors downregulated in Mll1FC/FC;
Lgr5-eGFP-CreERT2/+ compared to control ISCs (4 days after tamoxifen). Mean+s.d. is shown; n = 4; p<0.05, Wald test. (F)
DESeq normalized counts for genes coding for ISC markers downregulated in Mll1FC/FC; Lgr5-eGFP-CreERT2/+ compared
to control ISCs (4 days after tamoxifen). Mean+s.d. is shown; n = 4; p<0.05, Wald test. (G) Western blot analysis for
GATA4 protein on crypts from two pairs of Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ mice. GAPDH serves as loading control.
(H) Representative ChIP-qPCR analysis specific for H3K4me3 occupancy at promoter regions. Crypts from Mll1FC/+;
RC/+ or Mll1FC/FC; RC/+ mice were crosslinked and chromatin immunoprecipitation was performed with and without
(mock) H3K4me3 antibody. Target genes were selected from Table 1. Mean+s.d. is shown; n = 3 �p<0.05, ��p<0.01,
���p<0.001, Student’s t test.
https://doi.org/10.1371/journal.pgen.1009250.g004
Table 1. Common mRNAs downregulated after removal of MLL1 from ISCs and/or organoids.
Gene Description 4d het FD 10d het FD P1 het FD P3 het FD
Pitx2 Paired like homeodomain 2 1399.6 8.6 854.8 24.6 609.9 1.2� 758.4 12.1
Bahcc1 BAH domain and coiled-coil 1 66.4 3.8 47.7 8.1 657.7 2.4 1032 42.0
Foxa1 Forkhead box A1, Hnf3α 356.8 3.4 428.4 4.6 774.2 1.7 1135.9 2.0
Hspa8 Heat shock protein A8, Hsp70C 12104 2.6 7654.5 3.0 9935.3 2.1 12432 2.4
Zfp503 Zinc finger protein 503, Nolz1 113.2 2.5 166.7 7.9 683.9 2.5 775.7 2.8�
Pla2g2a Phospholipase A2 group IIA 291.3 2.5 215.7 3.2
Pitx1 Paired like homeodomain 1 71.8 2.3 75.5 6.4 1484.7 1.7 1128.9 16.4
Prss12 Protease serine 12 neurotrypsin, Motopsin 58.1 2.3 97.8 11.2 1054.5 1.5 938.3 4.7
Scn2b Sodium channel subunit 2b 460.6 2.2 545.3 1.8
Cerk Ceramide kinase 198.1 2.1 141.6 1.2� 2228.1 1.4 2918.8 2.2
Onecut2 Onecut homeobox 2, Hnf6β 2334.5 2.0 2411.9 4.1 4344.5 1.4�
Casc4 Cancer susceptible 4 120.5 2.0 255.1 2.7
Gata4 GATA binding protein 4 676.4 1.9 508.2 3.7 3535.0 1.4 5820.7 3.3
Far1 SID1 transmembrane family1 402.3 1.8 231.8 4.9
Fam149a Toll-like receptor 3? 170.7 1.8 193.9 2.1 435.3 1.2� 659.2 2.0
Klhl23 Kelch-like 23 383.8 1.7 291.5 1.4� 452.7 1.7 341 1.4�
Lmcd1 LIM & cysteine rich domains 1 432.8 1.2 263.6 2.1 210 1.6 248.2 2.2
Cdkn1b Cyclin-dependent kinase inhibitor 1B 330.8 1.6 482.3 1.6 1565.8 1.5 2882.6 1.8
Ces2g Carboxyl esterase 2 275.2 1.6 209.9 3.6 4055.9 2.8
Phlpp1 PH domain leucine rich phosphatase 468.7 1.6 480.5 2.1 481.6 1.5 932.0 1.8
Zfpm1 FOG1, Friend of Gata 1 198.5 1.4 216.6 2.0 3756.9 1.2 5252.1 1.7
Lcp1 Lymphocyte cytosolic P1 824.4 1.4 662.0 2.3 2904.3 1.1� 5092.5 2.6
Gdf9 Growth differentiation factor 9 190.7 2.0 771.3 10.5
Urad Ureidoimidazoline decarboxylase 70.3 1.7 128.5 9.8
lncRNA ENSMUST00000215098.2 4124 34.4 3779.4 33.3 3322.7 4.4 2828.2 6.4
lncRNA E230029C05R 221.9 1.9 203.4 2.9
Values listed in the ‘4d het’ and ‘10d het’ columns are mRNA read averages from RNA-seq experiments after crypt isolation and FACS sorting for GFP positive cells
from Mll1FC/+; Lgr5-eGFP-CreERT2/+ mice 4 days (4d) or 10 days (10d) after the final tamoxifen induction. The adjacent FD columns show Fold Down mRNA read average
change from the accompanying experiments with Mll1FC/FC; Lgr5-eGFP-CreERT2/+ mice.
Values listed in ‘P1 het’ and ‘P3 het’ are mRNA read averages from RNA-seq experiments with Mll1FC/+; RC/+ organoids passage 1 (P1) or passage 3 (P3) after 4-hydroxy
tamoxifen induction. The adjacent FD columns show Fold Down mRNA read average change from the accompanying experiments with Mll1FC/FC; RC/+ organoids.
All protein coding mRNAs� 1.4 FD in both 4 day or P1 het experiments were considered except those expressed less than 50 read average, which were excluded. Only
genes� 1.6 FD in at least two columns are shown. All data p value < 0.05 except those marked with an asterisk�. Using the same criteria, two long non-coding RNAs
also qualified and are listed at the bottom.
https://doi.org/10.1371/journal.pgen.1009250.t001
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to the RNA-sequencing mRNA reads (S5C Fig). Western blot analysis on crypts isolated from
Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ mice demonstrated downregulation of GATA4 protein (Fig
4G). Concordant with RNA-sequencing data from Mll1-deficient forebrain [52,53], mRNA for
the chromatin co-factor, Bahcc1 was downregulated (Table 1). BAHCC1 binds to H3K27me3
and sustains repression of target genes [54]. These data suggest that MLL1 maintains the tran-
scriptional identity of ISCs.
H3K4me3 chromatin immunoprecipitation indicated that Foxa1, Pitx1, Pitx2, Gata4, One-
cut2, Zfp503/Nolz1 and Bahcc1 promoters are direct targets for MLL1. However similar indica-
tions for Far1, Hspa8 or Ces2g were not obtained (Fig 4H). Notably two long non-coding
RNAs featured prominently in the list of downregulated transcripts (Table 1). One of these,
ENSMUST00000215098.2, overlaps with the last two exons of Jaml/Amica1 and was very
strongly downregulated. However this transcript appears to play no role in the regulation of
JAML expression, which remained unchanged after loss of MLL1 as evaluated by Western blot
analysis (S5D Fig).
Loss of MLL1 in ISCs provokes transcriptional changes in Paneth cells
ISCs are anchored in the crypt in close association with Paneth cells. In order to elucidate
whether the transcriptional changes in ISCs influenced the neighboring Paneth cells, we ana-
lyzed Paneth cell transcriptional profiles 4 days after deletion of Mll1 in Lgr5+ ISCs, to find 198
and 72 transcripts significantly up- or downregulated respectively (Fig 5A and S1 Data). The
most significant terms associated with downregulated mRNAs relate to perturbation of protein
folding and homeostasis in the endoplasmic reticulum (Fig 5B–5D). In contrast upregulated
mRNAs associate with metabolic changes. Strikingly, transcripts of genes belonging to all five
respiratory chain complexes were upregulated (Fig 5B–5D). Paneth cells normally utilize gly-
colysis with lactate as the end product whereas ISCs depend on mitochondrial oxidative phos-
phorylation [55]. These transcriptional changes suggest that loss of MLL1 in the stem cell
compartment provokes changes in Paneth cells and indeed expression of Paneth cell marker
genes was downregulated (Fig 5C and 5D).
Skewed differentiation of organoids after loss of MLL1
To evaluate the cell-intrinsic requirement of MLL1 in the small intestine, we isolated crypts
from Mll1F/+; RC/+ and Mll1F/F; RC/+ mice and cultured organoids [56]. After passaging, the
organoids were induced with 4-hydroxy tamoxifen for 24 hours on day 2. After further pas-
sages, the Mll1FC/FC; RC/+ organoids showed a gradual decrease in budding and increasingly
formed round, less differentiated cyst-like spheres (Fig 6A and 6B).
To unravel the molecular basis of the intestinal organoid requirement for MLL1, transcrip-
tome analyses of Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ organoids were evaluated after passages 1
and 3 (P1 and P3). Using paired end 100 bp reads, 38–64 million reads per sample with high
levels of uniqueness (74–81% at P1 and 68–88% at P3; S6A and S6B Fig) and comparable map-
ability (97%) were obtained. PCA revealed that all biological replicates clearly separated
according to genotype thereby lending confidence regarding data quality (S6C and S6D Fig).
To analyze DEGs, we applied DESeq2 analysis to the RNA-seq dataset. At P1 only 24 genes
were up- or downregulated at a 5% FDR (Fig 6C) including an exceptional concordance with
downregulated genes in the ISC RNA-seq (Table 1), namely the transcription factors Pitx2,
Foxa1, Zfp503, Pitx1 and Gata4 (Table 1 and S1 Data). Other commonly downregulated genes
include Bahcc1, Hspa8 and Prss12. In contrast, no significantly upregulated genes in common
between 4 day ISC and P1 organoid transcriptomes were observed, potentially reflecting the
different cellular compositions and circumstances between sorted ISCs and organoids in
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culture. DAVID analysis of the P1 organoid data showed that the upregulated transcripts
mainly related to diverse terms including ‘response to external stimulus’, ‘leukocyte cell-cell
adhesion’ and ‘cell response to chemical stimulus’ (Fig 6D). In contrast, the most significant
terms associated with downregulated transcripts after MLL1 removal were comparable to the
downregulated terms of the sorted ISCs (Fig 4B) including ‘cell fate commitment’, ‘negative
regulation of gene expression’ and ‘intestinal epithelial cell differentiation’ (Fig 6E). After P3,
many more (1629 and 434) genes were up- and downregulated at a 5% FDR (S6E Fig). The
downregulated transcripts primarily associated with metabolic changes potentially reflecting
the transition to spheroids (S6F Fig). Nevertheless, most of the prominent downregulated
mRNAs common to ISCs and P1 organoids were also downregulated at P3 (Table 1 and S7
Fig). The most significant terms associated with upregulated transcripts relate to ‘cell surface
Fig 5. RNA profiling of wt Paneth cells after deletion of Mll1 in the neighboring ISCs. (A) Wt Paneth cells
neighboring either Mll1FC/+; Lgr5-eGFP-CreERT2/+ or Mll1FC/FC; Lgr5-eGFP-CreERT2/+ ISCs were sorted 4 days after tamoxifen
induction was completed and were subjected to RNA profiling. MA plot visualizing the log2-fold change differences
according to expression levels. Red dots represent significant DEGs at a 5% FDR. (B) Enriched terms of biological
processes and pathways down- and upregulated using DAVID GO/BP/FAT and KEGG database. (C) GSEA shows
significant negative or positive correlation of genes from the GO ERAD pathway, GO oxidative phosphorylation and
Paneth cell signature gene set in wt Paneth cells neighboring either Mll1FC/FC; Lgr5-eGFP-CreERT2/+ or Mll1FC/+;
Lgr5-eGFP-CreERT2/+ ISCs. The Paneth cell signature gene set originates from [87]. NES: normalized enrichment score. (D)
DESeq normalized counts for selected genes differentially regulated in the ERAD pathway, oxidative phosphorylation
and Paneth cell signature gene set. Mean+s.d. is shown; n = 4; p<0.05, Wald test.
https://doi.org/10.1371/journal.pgen.1009250.g005
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receptor signaling pathway’, ‘regulation of cell communication’ and ‘regulation of signaling’
(S6G Fig). Additionally, ‘regulation of MAPK cascade’ and ‘Wnt signaling pathway’ were also
upregulated at P3 (S6G and S6H Fig). KEGG pathway analysis suggests rearrangements in the
extracellular matrix of organoids with laminins (e.g. Lama3, Lama5), fibronectins (e.g. Fn1)
and collagens (e.g. Col4a1, Col4a2) being more prevalent (S6H and S6E Fig). Notably 662 out
of 1629 upregulated transcripts (41%) were only expressed in Mll1FC/FC; RC/+ cyst like spheres
indicating a change in cell type specificity (S1 Data). These observations confirm that the
Fig 6. Mll1 deletion in organoids results in loss of budding and formation of spheres. (A) Differential interference
contrast (DIC) images of Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ organoids. Organoids were induced with 4-hydroxy
tamoxifen for 24 h. Upon passaging (P), the mutant starts to loose its budding morphology giving rise to an
undifferentiated cyst-like appearance. Scale bar 100 μm. (B) Quantification of number of buds per organoid shown in
A. Mean+s.d. is shown; �p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001, Student’s t test. (C) mRNA profiling of Mll1FC/
+; RC/+ and Mll1FC/FC; RC/+ intestinal organoids after passage 1. Volcano plot visualizing the log2-fold change differences
according to expression levels. Blue and red dots represent significant down- and upregulated DEGs, respectively, at a
5% FDR. (D, E) Enriched terms of biological processes after passage 1 upregulated (D) and downregulated (E) using
DAVID GO/BP/FAT.
https://doi.org/10.1371/journal.pgen.1009250.g006
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requirement for MLL1 is cell intrinsic and essential for the maintenance of crypt morphology
and budding in organoid cultures.
Overall the data establish that MLL1 sustains the expression of key ISC genes. Their
reduced expression after loss of MLL1 leads to a loss of ISCs, consequent loss of TA cells and
aberrant secretory cell differentiation biased towards goblet cells. These perturbations in intes-
tinal homeostasis lead to wasting and death of the mouse.
Discussion
Here we add a fourth stem cell to the known MLL1 repertoire of (i) HSCs [21,22], (ii) skeletal
muscle satellite cells [27] and (iii) postnatal neural stem cells (NSCs) [28]. Additionally, MLL1
is required to sustain salivary gland and intestinal cancer stem cells mutated in the Wnt path-
way [48,57,58]. Consequently, all known MLL1 functions relate to action in stem cells, which
suggests that MLL1 conveys an essential stem cell property. This possibility is enhanced by
comparison to the MLL1 paralogue, MLL2, whose known functions in adult mice do not relate
to stem cells rather to macrophages (for lipopolysaccharide response) or fertility [59–62].
To explore the idea that MLL1 conveys a key stem cell property, we inspected the transcrip-
tome profiles after conditional loss of MLL1 in the four adult/postnatal stem cell populations
[27,28,63] (S1 Data). Some overlap between two stem cell types was observed, however no fully
shared candidate regulators or gene expression programs were identified. Although deeper,
more systematic, transcriptome or cell biology approaches may reveal a shared MLL1 stem cell
property, the lack of concordance between MLL1 regulation of these four stem cell transcrip-
tomes is not unexpected. Previous work with MLL1 noted that direct target genes are not
shared between different cell types [63] and a similar observation was made for MLL2 [59].
That is, the regulation of gene expression by the Trithorax homologues, MLL1 and MLL2, var-
ies depending on the cell type and is not universal.
As documented here for ISCs and intestinal organoids, once again the strongest relation-
ship between the loss of MLL1 and cellular processes involves the downregulation of mRNAs
that regulate transcription. Upon loss of MLL1, downregulation of transcription factor
mRNAs include—(i) in HSCs; Mecom, Prdm16, Pbx1, Eya1, Meis1 and Hoxa9; (ii) in postnatal
NSCs; Nkx2.1, Nkx2.3; (iii) in satellite cells; Pax7 and now (iv) in ISCs; Pitx1, Pitx2, Foxa1,
Zfp503, Gata4 and Onecut2.
How does MLL1 regulate key lineage specific transcription factors differently in different
lineages? MLL1 and MLL2 are amongst the few proteins that include the CxxC zinc finger that
binds unmethylated CpG dinucleotides [24,64] as well as a PHD finger that binds H3K4me3
[65]. Hence, as suggested before [59], MLL1 and 2 have the potential ability to bind CpG island
promoters without the need for recruitment by sequence specific DNA binding transcription
factors. This potential accords with the observation that both MLL1 and 2 appear to be bound
at almost all active promoters [45,66]. Consequently additional factors are required to explain
the restricted transcriptional specificities of the MLLs. Notable in this regard, PAX7 is bound
to MLL1 when satellite cells are activated, and enhanced transcriptional activation from both
the Myf5 promoter, to initiate skeletal muscle replenishment, and the Pax7 promoter itself,
depends on MLL1 [27]. This suggests that key transcription factors can either acquire the abil-
ity to interact with MLL1 bound at target promoters or recruit MLL1 to target promoters, or
both.
Amongst the transcription factor mRNAs identified after loss of MLL1 in ISCs, Pitx2 is
prominent. Pitx2 was previously identified as a direct target of MLL1 in ESCs and HSCs/
hematopoietic progenitor cells [67,68]. PITX2 is a homeodomain protein responsible for left-
right asymmetric morphogenesis in the gut and proper positioning of the small intestine in the
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body cavity [69]. Also notably identified in ISCs are Foxa1 and Onecut2. Both genes, previously
known as Hnf3α and Hnf6α, are expressed in all epithelia of the gastrointestinal tract from its
embryonic origin into adulthood. Together with Math1, they are critical for goblet cell differ-
entiation and function [70,71]. Gata4, which has previously been described as an MLL1 target
gene [48,72], is also amongst the top downregulated mRNAs after loss of MLL1. Some aspects
of the intestine specific deletion of Gata4 in the adult mouse resemble the MLL1 phenotype
described here including decreased proliferation in the crypt with increased numbers of goblet
cells [73]. Also notable is downregulation of the chromatin accessory factor, BAHCC1, which
has recently been shown to bind H3K27me3 and loss of Bahcc1 expression led to loss of
H3K27me3-mediated repression of target genes, thereby defining an H3K27me3 mechanism
for repression that does not rely on Polycomb Repressive Complexes (PRCs) [54]. Hence
maintenance of Bahcc1 expression provides a further component for the maintenance of ISC
identity by MLL1 through repression of gene expression, potentially those involved in the
MAPK and Wnt signaling pathways [48].
Upon loss of MLL1, the close association between ISCs and Paneth cells in the crypt and
organoids is destabilized (Fig 7). We suggest that loss of niche integrity leads to secondary
alterations particularly in the Paneth cell transcriptome but also possible changes in niche
properties especially to the central ISC at the bottom of the crypt, which is flanked by two
Paneth cells and has long-term self-renewal potential compared to border ISCs [74]. Notably,
MLL1 regulates the positional identity of NSCs [28], which may be relevant to the positional
identity of the central ISC.
Deletion of Mll1 in organoid cultures resulted in a gradual transition from branched orga-
noids to spheroids. Under normal conditions, ISCs and Paneth cells reside in the tightly
curved organoid budding regions where adherence junctions and high curvature limits stem
Fig 7. MLL1 is essential for niche homeostasis. ISCs are anchored in the crypt in close association with Paneth cells.
Loss of MLL1 in ISCs causes transcriptional changes with downregulation of intestine specific transcription factors
such as Pitx1, Pitx2, Foxa1 and Gata4 as well as chromatin accessory factor Bahcc1. Subsequently loss of stem cell
identity perturbs Paneth cell identity accompanied with changes in metabolism and protein folding.
https://doi.org/10.1371/journal.pgen.1009250.g007
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cell expansion [75]. Loss of MLL1 provokes cellular changes that leads to the formation of
spheroids. Notably, the transition to spheroids was not accompanied by a loss of proliferation,
which stands in contrast to the loss of MLL1 in the crypt. This difference may be due to the
absence of mesenchymal tissue in organoids, which exhibit a complex dynamic in intestinal
crypts, or possibly de-differentiation of the ISCs in the organoids to an MLL1-independent
state.
Once again we report the remarkable specificity of regulated gene expression conveyed by a
Trithorax homologue. As described here, loss of MLL1 resulted in loss of transcriptional regu-
lation with subsequent significant functional consequences in the crypt. In ESCs, the expres-
sion of only one gene, Magoh2, entirely depends on MLL2. Removal of MLL2 resulted in the
suppression of Magoh2 expression by H3K27 methylation, followed by DNA methylation
[59,76] thereby providing more evidence supporting the conclusion that a primary function of
Trithorax action is to prevent Polycomb-Group repression [77]. These observations and con-
clusions with Magoh2 in ESCs were recently confirmed [78]. Selective gene specific anti-
repression could also explain the action of MLL2 on Pigp in macrophages [60] and MLL1 on
Hoxa9 in HSCs [26].
Despite a high degree of evolutionary conservation and near-ubiquitous expression, the
Trithorax homologues appear to regulate only a small number of genes in cell-type specific
patterns. As observed in other adult stem cells, MLL1 regulates the expression of transcription
factors in ISCs that maintain stem cell identity and likely influence lineage commitment deci-
sions. These observations lead to the attractive proposition that MLL1 is a master stem cell reg-
ulator. However, a unifying mechanism for this proposition remains to be identified.
Methods and materials
Ethics statement
Experiments were performed in accordance with German animal welfare legislation, and were
approved by the relevant authorities, the Landesdirektion Dresden.
Targeting constructs
The targeting construct for Mll1 was generated using recombineering (S1A Fig) employing an
engrailed-intron-splice-acceptor-IRES-LacZ-Neomycin-polyA cassette flanked by FRT sites
[44]. The critical exon 2, which upon deletion results in a frameshift and a premature stop
codon in exon 3, was flanked by loxP sites.
Gene targeting and generation of conditional knockout mice
Gene targeting in R1 embryonic stem cells (ESCs) was performed as described [79]. Correct
integration in the Mll1 locus was confirmed by Southern blot analysis using 5’ and 3’ external
probes and a LacZ internal probe (S1B and S1C Fig). Two correctly targeted ESC clones were
injected into blastocysts and gave rise to several chimeras, which were able to establish germ
line transmission. Mll1A/+ mice were crossed to the hACTB-Flpe line to generate Mll1F/+ mice.
Mll1A/+ and Mll1F/+ mice were backcrossed at least six generations to C57BL/6JOlaHsd mice.
Subsequently, those mice were crossed to the Rosa26-Cre-ERT2 (RC) line [42] to generate con-
ditional, tamoxifen-inducible Mll1F/+; RC/+ mice. Mll1F/+ mice were bred with Lgr5-eGFP--
CreERT2 and Villin-CreERT2 (Vil-Cre-ERT2) [30,49] mice. Primers for genotyping are
provided in S2 Table.
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Tamoxifen
Tamoxifen (Sigma Aldrich, T5648) was given to at least 10-week old mice by gavage (4.5 mg
per day) for six days with three days break in between [80]. For RNA-Sequencing experiments,
Mll1F/+; Lgr5-eGFP-CreERT2/+ and Mll1F/F; Lgr5-eGFP-CreERT2/+ mice received 1 mg tamoxifen via
intraperitoneal (IP) injection for 3 consecutive days. To obtain Mll1-deficient crypts Mll1F/F;
RC/+ and Mll1F/+; RC/+ mice received tamoxifen (4.5 mg per day) via gavage for four days and
were sacrificed seven days after the final gavage. Intestinal organoids were induced on day 2
after splitting using 800 nM 4-hydroxy tamoxifen (Sigma Aldrich, H7904) for 24 h.
Bone marrow transplantation
Mll1F/+; RC/+ and Mll1F/F; RC/+ recipient (CD45.2) mice were lethally irradiated with 8.5 Gy (X-
ray source MaxiShot from Yxlon). Bone marrow cells from B6.SJL mice (CD45.1) were pre-
pared by crushing femurs and tibiae with a mortar and pestle in ice-cold PBS supplemented
with 5% fetal bovine serum. Red blood cells were removed with ACK lysis buffer (Thermo
Fisher Scientific). 1 x 106 lineage depleted (Lin-) bone marrow cells were injected into the
retro-orbital venous plexus. Animals were maintained on water containing 1.17 mg/ml neo-
mycin (Merck) for three weeks after irradiation. Complete donor cell engraftment of wt
CD45.1+ cells was confirmed by flow cytometry on peripheral blood with antibodies directed
against the following murine antigens (clones given in brackets): CD45.1 (A20), CD45.2 (104),
CD11b (M1/70), Gr-1 (RB6-8C5). Stably engrafted mice were fed six times with tamoxifen 30
weeks after transplantation. FACS analysis for KSL-Slam enriched HSCs was done with anti-
bodies directed against the following murine antigens: CD3 (2C11; 17A2), CD11b (M1/70),
CD16/32 (93), CD19 (eBio 1D3), CD34 (RAM34), CD45.1 (A20), CD45.2 (104), CD45R
(RA3-6B2), CD117 (2B8), CD135 (A2F10), Gr-1 (RB6-8C5), Nk1.1 (PK136), Ter119 (Ter119,
all eBioscience), CD11b (M1/70) and CD45.1 (A20, all BD Pharmingen), Sca-1 (D7), CD48
(HM48-1) and CD150 (TC15-12F1, all BioLegends). Lin- cells were identified by lack of CD3,
CD11b, CD19, CD45R, Gr-1, Nk1.1 and Ter119 expression.
5-Bromo-2-deoxyuridine (BrdU) assay
Mice were injected IP with BrdU (0.6 mg/10 g body weight in sterile PBS) and sacrificed 2 h
later. The jejunum was dissected in cold PBS and processed for immunohistochemistry.
Histochemistry and immunohistochemistry
Mouse intestine was flushed gently with cold PBS. Embryos were dissected from plugged mice
on the respective gestational stage and placed in PBS. Intestine and embryos were fixed in 4%
paraformaldehyde overnight. Dehydration and paraffin infiltration utilized the Paraffin-Infil-
tration-Processor (STP 420, Zeiss). Dehydrated tissues were embedded in paraffin (Paraffin
Embedding Center EG1160, Leica) and 5 μm sections were prepared. Sections were deparaffi-
nized in xylene, rehydrated through a series of alcohols, stained, dehydrated, and mounted.
Femur sections were stained with Giemsa according to standard protocols. For the basic evalu-
ation of the intestine hematoxylin and eosin (H&E) stain was performed. Periodic acid-Schiff
(PAS) stain and alcian blue were used to identify goblet cells. For enterocytes, alkaline phos-
phatase stain was performed using two different methods. Sections were either incubated with
Red Alkaline Phosphatase Substrate (Vector red, Vector Laboratories) for 10 minutes (min) or
with nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate solution for 30 min at
room temperature (RT). For immunohistochemistry, antigen retrieval was performed by
microwaving slides in 10 mM citrate buffer (pH 6.0) for 12 min (Microwave RHS 30, Diapath).
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Endogenous peroxidases were quenched with 0.3% H2O2 in methanol. Sections were incu-
bated in blocking serum (5% goat serum) for 1 hr at RT followed by overnight incubation with
primary antibodies (S3 Table) at 4˚C. Following incubation with the secondary antibody (S3
Table) the immune peroxidase was detected using a Vectastain ELITE ABC kit (Vector) and
visualized with a solution of diaminobenzidine (Sigma Aldrich) in the presence of 0.01%
H2O2. All sections were counterstained with hematoxylin or alcian blue. Images were collected
with an Olympus WF upright microscope and analyzed using the MetaMorph Microscopy
Automation and Image Analysis Software.
In situ hybridization
The protocol for in situ hybridization was modified from [81]. Briefly, 8 μm thick sections
were rehydrated. The sections were treated with 0.1 N HCl and proteinase K. Slides were post-
fixed and sections were then demethylated with acetic anhydride and prehybridized. Hybrid-
ization was done with 2 μg/ml digoxigenin (DIG)-labeled Olfm4 RNA probe for 24 h at 65˚C.
Slides were washed and incubated with blocking solution for 1 hr. The sections were incubated
with anti-DIG-alkaline phosphatase conjugate overnight at 4˚C. Slides were washed and devel-
oped with BM purple.
Crypt isolation
The jejunum was harvested from mice, flushed with ice cold PBS to remove any faecal content
and cut open longitudinally. The tissue was placed lumen side up on a petri dish and the villi
were removed by gently scraping the tissue using a glass cover slip. The tissue was cut into 2–4
cm pieces and was washed several times with ice-cold PBS to remove residual villi fragments.
Tissues were transferred into a fresh tube containing 15 ml of 2 mM EDTA/PBS chelation
buffer and placed on a rotating wheel for 30 min at 4˚C. The crypts were then detached from
the basal membrane by vigorous shaking in 5% FCS/PBS solution. The suspension was filtered
with a 100 μm cell strainer followed by a 70 μm cell strainer. Isolated crypts were centrifuged
at 800 rpm for 5 min at 4˚C. The final fraction consisted of pure crypts and was used for orga-
noid culture or single cell dissociation.
Organoid culture
Purified crypts were resuspended in 10 ml DMEM/F12 (Life Technologies). 10 μl of the crypt
suspension was used to count the number of crypts under the microscope. The pelleted crypts
were resuspended in Matrigel matrix (Corning) at desired crypt density. Approximately, 400
crypts in 25 μl Matrigel matrix were seeded per well in a pre-warmed 24-well plate and incu-
bated for 15 min at 37˚C until the Matrigel matrix solidified. Then, 400 μl of IntestiCult Orga-
noid Growth Medium (STEMCELL Technologies) was added to each well. Organoids were
cultured at 37˚C in a 5% CO2 incubator and maintained in culture for 5 days before being pas-
saged and split for experimental procedures. The growth medium was replaced every 2–3
days. Organoids at passage 1 and 3 on day 5 were washed with PBS and total RNA was
extracted using Trizol.
Flow cytometry
ISCs were initially characterized and identified with the use of an Lgr5-eGFP-CreERT2 knockin
allele [30]. Mll1F/+; Lgr5-eGFP-CreERT2/+ and Mll1F/F; Lgr5-eGFP-CreERT2/+ littermates (n = 4) were
given tamoxifen via IP injections for 3 consecutive days and were dissected 4 and 10 days later.
Crypts were dissociated into single cells with TrypLE Express (Thermo Fisher Scientific) for 30
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min at 37˚C. Dissociated cells were passed through 70 μm cell strainer and washed with 5%
FCS/PBS. Cells were stained with antibodies with the following antibodies for 45 min on ice:
anti-mouse CD24 PE (clone M1/69), anti-mouse CD326 (EpCAM) APC (clone G8.8), anti-
mouse CD45 Alexa-Fluor 700 (clone 104). Sorting was performed on a FACS Aria III cell
sorter (BD). After scatter discrimination to remove doublets the cell suspension was negatively
selected with SYTOX blue dead cell stain and anti-CD45 to remove dead and hematopoietic
cells, respectively. The cells where then positively selected with anti-EpCAM to enrich for
intestinal epithelial cells. According to [82] CD45-, EpCAMhigh, CD24med and GFPhigh charac-
terized ISCs and CD45-, EpCAMhigh, CD24high and GFP- characterized Paneth cells (S3A and
S3B Fig). Mll1 recombination via PCR on the sorted populations confirmed deletion of Mll1
solely in the stem cell compartment (S3C Fig).
RNA sequencing
300 intestinal stem and Paneth cells were sorted into 2 μl of nuclease free water with 0.2% Tri-
ton-X 100 and 4 U murine RNase Inhibitor (NEB). RNA was reverse transcribed (Invitrogen)
and cDNA amplified using Kapa HiFi HotStart Readymix (Roche). The cDNA quality and
concentration was determined with the Fragment Analyzer (Agilent). Samples were subjected
to library preparation (TruePrep DNA library Prep Kit V2 for Illumina, Vazyme). Libraries
were purified followed by Illumina sequencing on a Nextseq500 with a sample sequencing
depth of 30 million reads on average.
mRNA was enriched from 500 ng total RNA from organoids of the respective genotype by
poly-dT enrichment using the NEBNext Poly(A) mRNA Magnetic Isolation Module according
to the manufacturer’s instructions. The polyadenlyated RNA fraction was eluted in first strand
cDNA synthesis buffer (NEBnext, NEB). After chemical fragmentation samples were directly
subjected to the workflow for strand specific RNA-seq library preparation (Ultra II Directional
RNA Library Prep, NEB). Libraries were purified, quantified using the Fragment Analyzer
(Agilent) and sequenced on an Illumina Novaseq 6000 with 2x 100 bp reads using a S4 flowcell
to an average depth of 50 million read pairs.
The short reads were aligned to the mm10 transcriptome with GSNAP (2018-07-04 and
2020-12-16) and a table of read counts per gene was created based on the overlap of the
uniquely mapped reads with the Ensembl Gene annotation (version 92 and 98), using feature-
Counts (version 1.6.3 and 2.0.1). Normalization of the raw read counts based on the library
size and testing for differential gene expression between the different genotypes was performed
using the DESeq2 R package (version 1.24.0 and 1.20.0). Genes with an adjusted p-value
(padj)� 0.05 were considered as significantly differentially expressed accepting a 5% FDR. To
identify enrichment for particular biological processes and pathways associated with the
DEGs, the DAVID GO/BP/FAT and KEGG database [83] was used. Gene set enrichment anal-
ysis was performed using GSEA software from the Broad Institute [84].
Reverse transcription and quantitative PCR (qRT-PCR) analysis
RNA from sorted cells was extracted using Trizol (Sigma-Aldrich) and reverse transcribed
using AffinityScript Multiple Temperature cDNA Synthesis Kit (Agilent Technologies). Real-
time quantitative PCR was performed with GoTaq qPCR Master Mix (Promega) by Mx3000P
QPCR System (Agilent Technologies). Ct values were normalized against Rpl19. Primer
sequences and length of the amplified products are given in S2 Table. Fold differences in
expression levels were calculated according to the 2-ΔCt method [85].
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ChIP-qPCR
ChIP-qPCR was performed as previously described [4,45,86]. In brief, equal amounts of crypts
were crosslinked by adding formaldehyde followed by addition of glycine to quench the form-
aldehyde. After a wash with ice cold PBS the cells were harvested and lysed. Sonication was
performed with a water bath sonicator (BioRuptor, Diagenode) for 20 min at high power, 30
seconds ON, 30 seconds OFF resulting in DNA fragments of 200–600 bp. Immunoprecipita-
tion was performed using an antibody against H3K4me3 (ab8580; Abcam). A mock control
without addition of antibody was always performed in parallel. After washing the immune
complexes were eluted with 500 μl 1% SDS, 0.1 M NaHCO3 for 30 min, NaCl was added to a
final concentration of 200 mM and samples were de-crosslinked overnight at 65˚C. Samples
were extracted with phenol/chloroform/isoamylalcohol, isopropanol-precipitated in the pres-
ence of 20 μg glycogen and resuspended in water. The immunoprecipitated DNA was ampli-
fied by qPCR using primers flanking the promoter region (S2 Table). ChIP-qPCR data were
normalized with percentage of input analysis. This method represents the amount of DNA
pulled down by using the antibody of interest in the ChIP reaction, relative to the amount of
starting material (input sample).
Western blot analysis
Crypt and organoid pellets were resuspended in ice-cold RIPA buffer supplemented with 1x
cOmplete Protease Inhibitor Cocktail (Roche) and PMSF for 15 min on ice, centrifuged
(13200 rpm, 4˚C, 15 min) and supernatant was collected. Whole cell extracts were separated
by SDS-PAGE (10% Tris-glycine gel) and transferred to a PVDF membrane. Blots were probed
with primary antibodies (S3 Table).
Quantification and statistical analysis
Data is presented as mean and error bars indicate standard deviation (s.d.) unless otherwise
indicated. Statistical details of the experiments can be found in the figure legends. Graphs and
statistics were generated with GraphPad Prism software (v6.0) and Microsoft Excel. Signifi-
cance (p-values) for Kaplan-Meier graphs was determined by Mantel-Cox test. Significance
for differential gene expression (p-values < 0.05) was determined with Wald test. Significance
for the breeding statistics was determined with Chi-square test. All other graphs are computed
with two-tailed Student’s t test. N indicates the numbers of independent biological replicates
per experiment unless otherwise indicated.
Supporting information
S1 Fig. Mll1 gene targeting, embryonic phenotype and aspects of expression. (A) Diagram
of the Mll1 gene with numbered exons and the multipurpose allele (Mll1A). This allele is con-
verted to Mll1F upon FLP recombination. Cre recombination leads to excision of the frame-
shifting exon 2 generating the conditional mutant allele (Mll1FC). Genotyping primers are
depicted for the downstream loxP site (loxP1 –loxP2) and for Flp recombination (Flp se–
loxP2). SA = splice acceptor, IRES = internal ribosome entry site, pA = polyadenylation signal,
lacZ-neo = β-galactosidase and neomycin resistance gene, � depicts premature stop codon. (B)
Schematic representation of the Southern blot strategy. For identifying correct targeted events
in the Mll1 locus, Southern blot analysis employed 5’ (blue box), 3’ (red box) and internal LacZ
(green box) probes. (C) Southern blot analysis with 5’ external probe (wt and correctly targeted
ESC clone). Southern blot analysis with 3’ external and LacZ internal probes (wt ESCs and
organs from an adult Mll1A/+ mouse). (D) Dissected embryos from Mll1A/+ intercrosses at
PLOS GENETICS MLL1 is required for maintenance of intestinal stem cells
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1009250 December 3, 2021 20 / 28
E12.5. Mll1A/A embryos had a pale liver (marked by arrow). (E) Antibody staining (brown)
shows that MLL1 is expressed in crypts and TA compartment of the small intestine but is
absent in the villus (hematoxylin, purple). Scale bar 50 μm. (F) Normalized RNA-sequence
counts for Mll1/Kmt2a, Mll2/Kmt2b, Mll3/Kmt2c, Mll4/Kmt2d, Setd1a/Kmt2f and Setd1b/
Kmt2g in ISCs (eGFPhigh) and Paneth cells sorted from Lgr5-eGFP-CreERT2 mice. Mean+s.d.
is shown; n = 4; �p<0.05, ��p<0.01, ���p<0.001, ����p<0.0001, Student’s t test. (G) Antibody
stainings of H3K4me1, H3K4me2 and H3K4me3 are comparable in Mll1FC/+; RC/+ and Mll1FC/
FC; RC/+ intestinal sections. Scale bars are 100 μm.
(TIF)
S2 Fig. Without bone marrow transplantation, Mll1 deletion recapitulates the BMTx Mll1
mutant phenotype. (A) Kaplan-Meier analysis for the onset of diarrhea. Tamoxifen was given
by gavage for 6 days to Mll1F/+; RC/+ (n = 11) and Mll1F/F; RC/+ (n = 11) mice. The first day of
tamoxifen gavage was day zero. While all mice with the genotype Mll1FC/+; RC/+ remained
healthy, all Mll1FC/FC; RC/+ mice developed diarrhea with a median of 11 days. (B) Antibody
stain (left panels) and in situ hybridization (right panels) to visualize OLFM4/Olfm4 in intesti-
nal sections. Arrowheads point towards ISCs. Scale bar 100 μm. (C) Proliferative activity visu-
alized by both Ki67 stain and BrdU incorporation in intestinal sections. Arrowheads point
towards proliferative ISCs. Scale bars are 50 μm. (D) PAS staining and GOB5 antibody stain to
visualize goblet cells in intestinal sections. Scale bars are 100 μm. (E) Chromogranin A and
alkaline phosphatase staining to visualize enteroendocrine cells and enterocytes respectively.
Arrows point to enteroendocrine cells (brown cytoplasmic stain) in the villi. Blue enterocytes
covering the villi are marked by arrowheads. Scale bars are 100 μm for chromogranin A and
50 μm for alkaline phosphatase. (F) Nuclear β-catenin is comparable between the two different
genotypes. Arrowheads point at β-catenin positive nuclei. Scale bar is 50 μm. (G) Left and mid-
dle panels; antibody stainings to visualize OLFM4 and Ki67 expression in Mll1FC/FC; Vil-Cre-
ERT2/+ intestine compared to controls, four weeks after the first gavage. Hematoxylin was used
as a counterstain for OLFM4 and alcian blue was used for Ki67 IHC. Right panel; alcian blue
staining of goblet cells with NFR to stain nuclei, four weeks after the first gavage. Scale bars are
100 μm.
(TIF)
S3 Fig. FACS gating strategy to sort ISCs and Paneth cells. Flow sorting on (A) Mll1FC/+;
Lgr5-eGFP-CreERT2/+ and (B) Mll1FC/FC; Lgr5-eGFP-CreERT2/+ single cell suspension of crypts. Briefly,
the consecutive gating steps were applied: (i)–(iii) Definition of the population of interest by
exclusion of debris based on size (FSC), granularity (SSC) and the selection for single cells; (iv)
Exclusion of dead cells that incorporated the nucleic acid stain SYTOX blue; (v) Depletion of
CD45pos population; (vi) Definition of Paneth (EpCAMhigh/CD24high) cell population by plot-
ting EpCAM vs CD24 fluorescence; (vii) EpCAMhigh/CD24med cell population was gated to
discriminate the stem cell population (GFPhigh). (C) Stem cells (SC) and Paneth cells (PC)
from Mll1FC/+; Lgr5-eGFP-CreERT2/+ and Mll1FC/FC; Lgr5-eGFP-CreERT2/+ mice 4 days after tamoxifen
induction were checked for recombination. Left panel; PCR genotyping was using primers (as
shown in S1A Fig) upstream of the 5’ FRT site and downstream of the 3’ loxP site identified
the Mll1F band at 1084 bp, the wild type band a 933 bp and the Mll1FC band at 186 bp. Right
panel; primers flanking the 3’ loxP site identified the Mll1F band at 297 bp and the wild type
band at 251 bp.
(TIF)
S4 Fig. Alignment and quality of the sequenced data. (A) ISCs and Paneth cells were ana-
lyzed from control (Mll1FC/+; Lgr5-eGFP-CreERT2/+) (ctrl) (n = 4) and Mll1FC/FC; Lgr5-eGFP-CreERT2/+
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(n = 4) (KO) mice. Mapability of reads for sorted ISCs 4 days after tamoxifen induction was
completed. (B) Mapability of reads for sorted Paneth cells 4 days after tamoxifen induction
was completed. (C) Mapability of reads for sorted ISCs 10 days after tamoxifen induction was
completed. ISCs were analyzed from control (Mll1FC/+; Lgr5-eGFP-CreERT2/+) (ctrl) (n = 4) and
Mll1FC/FC; Lgr5-eGFP-CreERT2/+ (n = 3) (KO) mice. (D) Principal-component analysis (PCA) was
performed on Paneth cell and ISC samples sorted 4 days after tamoxifen. PCA is based on
mRNA changes for the top 500 most diverse genes of stem cell (SC) and Paneth cell (PC) sam-
ples in comparison to published datasets for Lgr5+ SC [51] and CD24+ PC [37].
(TIF)
S5 Fig. ISCs lacking MLL1 loose their cellular identity. (A) (B) GSEA shows significant neg-
ative or positive correlation of genes from the stem (A) and goblet cell (B) signature gene set in
Mll1FC/FC; Lgr5-eGFP-CreERT2/+ ISCs compared to control ISCs 10 days after tamoxifen induction
was completed. The signature gene sets originate from [87]. NES: normalized enrichment
score. (C) To validate RNA-seq results qRT-PCR was performed for selected genes on cDNA
from Mll1FC/+; Lgr5-eGFP-CreERT2/+ and Mll1FC/FC; Lgr5-eGFP-CreERT2/+ sorted stem cells 4 days after
tamoxifen induction was completed. Mean+s.d. is shown; n = 3; �p<0.05, ��p<0.01, Student’s
t test. (D) Western blot analysis shows no change in JAML protein levels in Mll1FC/+; RC/+,
Mll1FC/FC; RC/+ and Mll1F/F; RC/+ organoids (n = 2). GAPDH is the loading control.
(TIF)
S6 Fig. mRNA profiling of Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ organoids. (A, B) Intestinal
organoids were analyzed from Mll1FC/+; RC/+ (ctrl) (n = 3) and Mll1FC/FC; RC/+ (KO) (n = 3)
mice. Mapability of reads after passage 1 (A) and passage 3 (B). (C, D) Principal-component
analysis (PCA) was performed on intestinal organoids after passage 1 (C) and passage 3 (D).
PCA is based on mRNA changes for the top 500 most diverse genes. (E) mRNA profiling of
Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ intestinal organoids after passage 3. Volcano plot visualizing
the log2-fold change differences according to expression levels. Blue and red dots represent
significant down- and upregulated DEGs, respectively, at a 5% FDR. (F-H) Enriched terms of
biological processes and pathways downregulated (F) and upregulated (G, H) using DAVID
GO/BP/FAT and KEGG database.
(TIF)
S7 Fig. Differential gene expression in Mll1FC/+; RC/+ and Mll1FC/FC; RC/+ organoids. RNA-
seq tracks showing the read coverage of different gene loci derived from Mll1FC/+; RC/+ (top
three rows) and Mll1FC/FC; RC/+ (bottom three rows) intestinal organoids after passage 3. Gene
diagrams are depicted below. The tracks were generated with the Integrative Genomics
Viewer.
(TIF)
S1 Table. Embryonic lethality of Mll1A/A embryos.
(PDF)
S2 Table. Primers for genotyping, qRT-PCR and ChIP-qPCR.
(PDF)
S3 Table. Antibodies for immunohistochemistry staining and Western blot.
(PDF)
S1 Data. List of up- and downregulated transcripts from sorted stem cells, sorted Paneth
cells and organoids with a p value<0.05.
(XLSX)
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